phase readout
saveNCT06079372: Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa
ACTIVE_NOT_RECRUITINGupdated 11d ago
community read0 votes
Sponsor: Alexion Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Hypophosphatasia
view source ↗
comments(0)
5-min edit window · permanent after that